Login/Sign Up
Mircera 50mcg Injection 0.3 ml belongs to a class of drugs known as erythropoiesis-stimulating agents (ESA). Mircera 50mcg Injection 0.3 ml is primarily used to treat anaemia (lack of haemoglobin in blood) due to chronic kidney disease in adults and children over five years. Anaemia describes as reduced levels of haemoglobin and red blood cells (RBCs) in the blood. Chronic kidney disease (CKD) patients slowly develop anaemia, which worsens as the disease progresses. Then the kidneys partially lose their functions permanently in CKD.
Mircera 50mcg Injection 0.3 ml contains ‘Methoxy polyethylene glycol and Epoetin beta’. Mircera 50mcg Injection 0.3 ml works by stimulating the bone marrow (soft tissue within the bones that makes red blood cells) to make more red blood cells. This Mircera 50mcg Injection 0.3 ml is very similar to the natural substance in the body known as erythropoietin (hormone formed by kidneys and produced RBC) which prevents anaemia (lack of haemoglobin and RBC in the blood).
Mircera 50mcg Injection 0.3 ml will be administered by a healthcare professional; do not self-administer. The common side-effects of Mircera 50mcg Injection 0.3 ml are pain, itching, swelling or redness around the injection site, high blood pressure, vomiting, diarrhoea, headache, constipation, stomach pain, back pain, and pain in your legs or hands, fever and chills. Most of these side effects of Mircera 50mcg Injection 0.3 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are known to be allergic to Mircera 50mcg Injection 0.3 ml or any other medicines, please tell your doctor. Mircera 50mcg Injection 0.3 ml should not be taken in conditions like high blood pressure. If you are pregnant or a nursing mother, it is advised to consult a doctor before using Mircera 50mcg Injection 0.3 ml. Mircera 50mcg Injection 0.3 ml should not be used for children below five years of age. Mircera 50mcg Injection 0.3 ml does not affect your ability to drive and use machines.
Mircera 50mcg Injection 0.3 ml is primarily used to treat anaemia (lack of haemoglobin in blood) due to chronic kidney disease in adults and children over five years. Mircera 50mcg Injection 0.3 ml decreases the requirement for blood cell transfusions. Mircera 50mcg Injection 0.3 ml is not used to treat anaemia caused by cancer chemotherapy. Mircera 50mcg Injection 0.3 ml works by stimulating the bone marrow (soft tissue within the bones that makes red blood cells) to make more red blood cells. This Mircera 50mcg Injection 0.3 ml is very similar to the natural substance in the body known as erythropoietin (hormone formed by kidneys and produced RBC) which prevents anaemia (lack of haemoglobin and RBC in the blood).
If you are known to be allergic to Mircera 50mcg Injection 0.3 ml or any other medicines, please tell your doctor. Mircera 50mcg Injection 0.3 ml should not be taken in conditions like high blood pressure, heart disease, fit disorder/ epilepsy, dialysis treatment or cancer. Before taking Mircera 50mcg Injection 0.3 ml, inform your doctor if you ever had anaemia. Inform your doctor if you feel weak, tired or have shortness of breath. Healthy people should not take Mircera 50mcg Injection 0.3 ml as it can lead to too much haemoglobin level and further cause heart disease that may be life-threatening. If you are pregnant or a nursing mother, it is advised to consult a doctor before using Mircera 50mcg Injection 0.3 ml. Mircera 50mcg Injection 0.3 ml should not be used for children below five years of age. Mircera 50mcg Injection 0.3 ml does not affect your ability to drive and use machines.
Drug-Drug Interaction: No interactions found.
Drug-Food Interaction: No interactions found.
Drug-Disease Interaction: Mircera 50mcg Injection 0.3 ml should not be used in patients with high blood pressure on chemotherapy.
Anaemia: Anaemia is described as reduced levels of haemoglobin and red blood cells (RBCs) in the blood. Chronic kidney disease (CKD) patients slowly develop anaemia, which worsens as the disease progresses. Then the kidneys partially lose their functions permanently in CKD. There is insufficient erythropoietin (hormone formed by kidneys and produced RBC) formation. This hormone helps the production of RBCs by the bone marrow. As a result, RBCs production is affected, leading to fewer RBCs than normal.
About Mircera 50mcg Injection 0.3 ml
Mircera 50mcg Injection 0.3 ml belongs to a class of drugs known as erythropoiesis-stimulating agents (ESA). Mircera 50mcg Injection 0.3 ml is primarily used to treat anaemia (lack of haemoglobin in blood) due to chronic kidney disease in adults and children over five years. Anaemia describes as reduced levels of haemoglobin and red blood cells (RBCs) in the blood. Chronic kidney disease (CKD) patients slowly develop anaemia, which worsens as the disease progresses. Then the kidneys partially lose their functions permanently in CKD.
Mircera 50mcg Injection 0.3 ml contains ‘Methoxy polyethylene glycol and Epoetin beta’. Mircera 50mcg Injection 0.3 ml works by stimulating the bone marrow (soft tissue within the bones that makes red blood cells) to make more red blood cells. This Mircera 50mcg Injection 0.3 ml is very similar to the natural substance in the body known as erythropoietin (hormone formed by kidneys and produced RBC) which prevents anaemia (lack of haemoglobin and RBC in the blood).
Mircera 50mcg Injection 0.3 ml will be administered by a healthcare professional; do not self-administer. The common side-effects of Mircera 50mcg Injection 0.3 ml are pain, itching, swelling or redness around the injection site, high blood pressure, vomiting, diarrhoea, headache, constipation, stomach pain, back pain, and pain in your legs or hands, fever and chills. Most of these side effects of Mircera 50mcg Injection 0.3 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are known to be allergic to Mircera 50mcg Injection 0.3 ml or any other medicines, please tell your doctor. Mircera 50mcg Injection 0.3 ml should not be taken in conditions like high blood pressure. If you are pregnant or a nursing mother, it is advised to consult a doctor before using Mircera 50mcg Injection 0.3 ml. Mircera 50mcg Injection 0.3 ml should not be used for children below five years of age. Mircera 50mcg Injection 0.3 ml does not affect your ability to drive and use machines.
₹4428*
MRP ₹5400
18% off
₹4590*
MRP ₹5400
15% CB
₹810 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Online payment accepted
Uses of Mircera 50mcg Injection 0.3 ml
Medicinal Benefits
Mircera 50mcg Injection 0.3 ml is primarily used to treat anaemia (lack of haemoglobin in blood) due to chronic kidney disease in adults and children over five years. Mircera 50mcg Injection 0.3 ml decreases the requirement for blood cell transfusions. Mircera 50mcg Injection 0.3 ml is not used to treat anaemia caused by cancer chemotherapy. Mircera 50mcg Injection 0.3 ml works by stimulating the bone marrow (soft tissue within the bones that makes red blood cells) to make more red blood cells. This Mircera 50mcg Injection 0.3 ml is very similar to the natural substance in the body known as erythropoietin (hormone formed by kidneys and produced RBC) which prevents anaemia (lack of haemoglobin and RBC in the blood).
Side Effects of Mircera 50mcg Injection 0.3 ml
Directions for Use
Storage
Drug Warnings
If you are known to be allergic to Mircera 50mcg Injection 0.3 ml or any other medicines, please tell your doctor. Mircera 50mcg Injection 0.3 ml should not be taken in conditions like high blood pressure, heart disease, fit disorder/ epilepsy, dialysis treatment or cancer. Before taking Mircera 50mcg Injection 0.3 ml, inform your doctor if you ever had anaemia. Inform your doctor if you feel weak, tired or have shortness of breath. Healthy people should not take Mircera 50mcg Injection 0.3 ml as it can lead to too much haemoglobin level and further cause heart disease that may be life-threatening. If you are pregnant or a nursing mother, it is advised to consult a doctor before using Mircera 50mcg Injection 0.3 ml. Mircera 50mcg Injection 0.3 ml should not be used for children below five years of age. Mircera 50mcg Injection 0.3 ml does not affect your ability to drive and use machines.
Therapeutic Class
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Anaemia: Anaemia is described as reduced levels of haemoglobin and red blood cells (RBCs) in the blood. Chronic kidney disease (CKD) patients slowly develop anaemia, which worsens as the disease progresses. Then the kidneys partially lose their functions permanently in CKD. There is insufficient erythropoietin (hormone formed by kidneys and produced RBC) formation. This hormone helps the production of RBCs by the bone marrow. As a result, RBCs production is affected, leading to fewer RBCs than normal.